Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study ; volume:8 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (12.9.2018), 1-10, 12.2018

Creator: Liu, Chen-Hua

Contributor: Huang, Yi-Jie
Yang, Sien-Sing
Chang, Chung-Hsin
Yang, Sheng-Shun
Sun, Hsin-Yun
Liu, Chun-Jen
Liu, Wen-Chun
Su, Tung-Hung
Yang, Hung-Chih
Hong, Chun-Ming
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Hung, Chien-Ching
Kao, Jia-Horng
SpringerLink (Online service)

DOI: 10.1038/s41598-018-32060-7

URN: urn:nbn:de:101:1-2018102520464836982301

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Chen-Hua
Huang, Yi-Jie
Yang, Sien-Sing
Chang, Chung-Hsin
Yang, Sheng-Shun
Sun, Hsin-Yun
Liu, Chun-Jen
Liu, Wen-Chun
Su, Tung-Hung
Yang, Hung-Chih
Hong, Chun-Ming
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Hung, Chien-Ching
Kao, Jia-Horng
SpringerLink (Online service)

Other Objects (12)

Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)

Viral recognition and the antiviral interferon response

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Hochschulschrift

Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity

Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)

Viral recognition and the antiviral interferon response

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Hochschulschrift

Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity

Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)

Viral recognition and the antiviral interferon response

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Hochschulschrift

Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)

Viral recognition and the antiviral interferon response

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity

Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)

Viral recognition and the antiviral interferon response

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity

Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)

Viral recognition and the antiviral interferon response

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Interferon‐inducible phospholipids govern IFITM3 ‐dependent endosomal antiviral immunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity

Related objects

Reset password